Current Research Information SysTem In Norway
 
 

 Norsk versjon


 
Mainpage
Research results/NVI
Researchers
Projects
Research units
Log in
About Cristin
 
 
   
Back to search     Short format     Full format    
Export to


Showing results 1-50 of 76 << Previous 1 2    Next >>

2020
1 Artenie, Andreea A.; Cunningham, Evan B.; Dore, Gregory J.; Conway, Brian; Dalgard, Olav; Powis, Jeff; Bruggmann, Philip; Hellard, Margaret; Cooper, Curtis; Read, Phillip; Feld, Jordan J.; Hajarizadeh, Behzad; Amin, Janaki; Lacombe, Karine; Stedman, Catherine; Litwin, Alain; Marks, Pip; Matthews, Gail V.; Quiene, Sophie; Erratt, Amanda; Bruneau, Julie; Grebely, Jason.
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study. Clinical Infectious Diseases 2020 ;Volume 70.(11) p. 2369-2376
AHUS Untitled
 
2 Hajarizadeh, Behzad; Cunningham, Evan B.; Valerio, Heather; Martinello, Marianne; Law, Matthew; Janjua, Naveed Z.; Midgard, Håvard; Dalgard, Olav; Dillon, John; Hickman, Matthew; Bruneau, Julie; Dore, Gregory J.; Grebely, Jason.
Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology 2020 ;Volume 72.(4) p. 643-657
AHUS OUS Untitled
 
3 Lyngbakken, Magnus; Berdal, Jan Erik; Eskesen, Arne N; Kvale, Dag; Inge Christoffer, Olsen; Rangberg, Anbjørg; Jonassen, Christine M.; Omland, Torbjørn; Røsjø, Helge; Dalgard, Olav.
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials 2020 ;Volume 21. p. -
AHUS OSTFSYK OUS UiO Untitled
 
4 Midgard, Håvard; Finbråten, Ane-Kristine; Malme, K.B.; Berg-Pedersen, Riikka Mari; Tanum, Lars Håkon Reiestad; Inge Christoffer, Olsen; Bjørnestad, Ronny; Dalgard, Olav.
Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs. Trials 2020 ;Volume 21.(1) p. 524-
AHUS OSLOMET LDS OUS UiO Untitled
 
2019
5 Fadnes, Lars T.; Aas, Christer Frode; Vold, Jørn Henrik; Ohldieck, Christian; Leiva, Rafael Alexander Mo; Chalabianloo, Fatemeh; Skurtveit, Svetlana; Lygren, Ole Jørgen; Dalgard, Olav; Vickerman, Peter; Midgard, Håvard; Løberg, Else-Marie; Johansson, Kjell Arne.
Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV). BMC Infectious Diseases 2019 ;Volume 19:943. p. 1-9
AHUS FHI HAUKELAND OUS UiB UiO Untitled
 
6 Gahrton, Caroline; Westman, Gabriel; Lindahl, Karin; Öhrn, Fredrik; Dalgard, Olav; Lidman, Christer; Nilsson, Lars-Håkan; Said, Karouk; Duberg, Ann-Sofi; Aleman, Soo.
Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County. BMC Infectious Diseases 2019 ;Volume 19.(1) p. -
AHUS UiO Untitled
 
7 Gulati, Rachna Shridhar; Wimalanathan, Thakshani; Andersen, Solveig Norheim; Isaksen, Kjetil; Lagging, Martin; Midgard, Håvard; Moghaddam, Amir; Dalgard, Olav.
The relationship between IFNL4 genotype and the rate of fibrosis in hepatitis C patients. Scandinavian Journal of Gastroenterology 2019 ;Volume 54.(9) p. 1172-1175
AHUS OUS SUS Untitled
 
8 Safreed-Harmon, Kelly; Blach, Sarah; Aleman, Soo; Bollerup, Signe; Cooke, Graham; Dalgard, Olav; Dillon, John F.; Dore, Gregory J.; Duberg, Ann-Sofi; Grebely, Jason; Kielland, Knut Boe; Midgard, Håvard; Porter, Kholoud; Razavi, Homie; Tyndall, Mark; Weis, Nina; Lazarus, Jeffrey V..
The Consensus Hepatitis C Cascade of Care: standardized reporting to monitor progress toward elimination. Clinical Infectious Diseases 2019 ;Volume 69.(12) p. 2218-2227
AHUS OUS SI UiO Untitled
 
2018
9 Bjøro, Benedikte; Dalgard, Olav; Midgard, Håvard; Verbaan, Hans; Småstuen, Milada Cvancarova; Rustøen, Tone.
Increased hope following successful treatment for hepatitis C infection.. Journal of Advanced Nursing 2018 ;Volume 74.(3) p. 724-733
AHUS OSLOMET OUS UiO Untitled
 
10 Cunningham, Evan B.; Amin, Janaki; Feld, Jordan J.; Bruneau, Julie; Dalgard, Olav; Powis, Jeff; Hellard, Margaret; Cooper, Curtis; Read, Phillip; Conway, Brian; Dunlop, Adrian J.; Norton, Briana; Litwin, Alain H.; Hajarizadeh, Behzad; Thurnheer, Maria Christine; Dillon, John F.; Weltman, Martin; Shaw, David; Bruggmann, Philip; Gane, Edward; Fraser, Chris; Marks, Philippa; Applegate, Tanya L.; Quiene, Sophie; Siriragavan, Sharmila; Matthews, Gail V.; Dore, Gregory J.; Grebely, Jason.
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. International journal of drug policy 2018 ;Volume 62. p. 14-23
AHUS UiO Untitled
 
11 Day, Emma; Hellard, Margaret; Treloar, Carla; Bruneau, Julie; Martin, Natasha K.; Øvrehus, Anne; Dalgard, Olav; Lloyd, Andrew; Dillon, John; Hickman, Matt; Byrne, Jude; Litwin, Alain; Matičič, Mojca; Bruggmann, Philip; Midgard, Håvard; Norton, Brianna; Trooskin, Stacey; Lazarus, Jeffrey V.; Grebely, Jason.
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Liver international (Print) 2018 p. 1-11
AHUS OUS UiO Untitled
 
12 Fraser, Hannah; Martin, Natasha K.; Brummer-Korvenkontio, Henrikki; Carrieri, Patrizia; Dalgard, Olav; Dillon, John; Goldberg, David; Hutchinson, Sharon; Jauffret-Roustide, Marie; Kåberg, Martin; Matser, Amy A.; Matičič, Mojca; Midgard, Håvard; Mravcik, Viktor; Øvrehus, Anne; Prins, Maria; Reimer, Jens; Robaeys, Geert; Schulte, Bernd; van Santen, Daniela Katinka; Zimmermann, Ruth; Vickerman, Peter; Hickman, Matthew.
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. Journal of Hepatology 2018 ;Volume 68.(3) p. 402-411
AHUS UiO Untitled
 
13 Grebely, Jason; Conway, Brian; Cunningham, Evan B.; Fraser, Chris; Moriggia, Alberto; Gane, Edward; Stedman, Catherine; Cooper, Curtis; Castro, Erika; Schmid, Patrick; Petoumenos, Kathy; Hajarizadeh, Behzad; Marks, Philippa; Erratt, Amanda; Dalgard, Olav; Lacombe, Karine; Feld, Jordan J.; Bruneau, Julie; Daulouede, Jean-Pierre; Powis, Jeff; Bruggmann, Philip; Matthews, Gail V.; Kronborg, Ian; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Applegate, Tanya L.; Crawford, Sione; Dore, Gregory J..
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy. International journal of drug policy 2018 ;Volume 62. p. 94-103
AHUS Untitled
 
14 Grebely, Jason; Dalgard, Olav; Conway, Brian; Cunningham, Evan B.; Bruggmann, Philip; Hajarizadeh, Behzad; Amin, Janaki; Bruneau, Julie; Hellard, Margaret; Litwin, Alain H.; Marks, Philippa; Quiene, Sophie; Siriragavan, Sharmila; Applegate, Tanya L.; Swan, Tracy; Byrne, Jude; Lacalamita, Melanie; Dunlop, Adrian; Matthews, Gail V.; Powis, Jeff; Shaw, David; Thurnheer, Maria Christine; Weltman, Martin; Kronborg, Ian; Cooper, Curtis; Feld, Jordan J.; Fraser, Chris; Dillon, John F.; Read, Phillip; Gane, Edward; Dore, Gregory J..
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. The Lancet Gastroenterology and Hepatology 2018 ;Volume 3.(3) p. 153-161
AHUS Untitled
 
15 Midgard, Håvard; Kielland, Knut Boe; Dalgard, Olav.
Eliminasjon av hepatitt C er mulig. Tidsskrift for Den norske legeforening 2018 ;Volume 138.(7) p. 630-633
AHUS OUS SI Untitled
 
16 Safreed-Harmon, Kelly; Hetherington, Kristina L.; Aleman, Soo; Alho, Hannu; Dalgard, Olav; Frisch, Tove; Gottfredsson, Magnus; Weis, Nina; Lazarus, Jeffrey V..
Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study. PLOS ONE 2018 ;Volume 13.(1)
AHUS Untitled
 
17 Wisløff, Torbjørn; White, Richard Aubrey; Dalgard, Olav; Amundsen, Ellen Johanna; Meijerink, Hinta; Kløvstad, Hilde.
Feasibility of reaching world health organization targets for hepatitis C and the cost‐effectiveness of alternative strategies. Journal of Viral Hepatitis 2018 ;Volume 25.(9) p. 1066-1077
AHUS FHI UiO Untitled
 
18 Wisløff, Torbjørn; White, Richard Aubrey; Dalgard, Olav; Amundsen, Ellen Johanna; Meijerink, Hinta; Løvlie, Astrid Louise; Kløvstad, Hilde.
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. PharmacoEconomics (Auckland) 2018 ;Volume 36.(5) p. 591-601
AHUS FHI UiO Untitled
 
2017
19 Blach, sarah; zeuzem, stefan; Manns, Michael; Altraif, Ibrahim; Duberg, Ann-Sofi; Muljono, David H; Waked, Imam; Alavian, Seyed M; Lee, Mei-Hsuan; Negro, Francesco; Abaalkhail, Faisal; Abdou, Ahmed; Abdulla, Maheeba; Rached, Antoine Abou; Aho, Inka; Akarca, Ulus; Ghazzawi, Imad Al; Kaabi, Saad Al; Lawati, Faryal Al; Namaani, Khalid Al; Serkal, Youssif Al; Al-Busafi, Said A; Al-Dabal, Layla; Aleman, Soo; Alghamdi, Abdullah S; Aljumah, Abdulrahman A; Al-Romaihi, Hamad E; Andersson, Monique I; Arendt, Vic; Arkkila, Perttu; Assiri, Abdullah M; Baatarkhuu, Oidov; Bane, Abate; Ben-Ari, Ziv; Bergin, Colm; Bessone, Fernando; Bihl, Florian; Bizri, Abdul R; Blachier, Martin; Blasco, Antonio J; Mello, Carlos E Brandao; Bruggmann, Philip; Brunton, Cheryl R; Calinas, Filipe; Chan, Henry L Y; Chaudhry, Asad; Cheinquer, Hugo; Chen, Chien-Jen; Chien, Rong-Nan; Choi, Moon Seok; Christensen, Peer B.; Chuang, Wan-Long; Chulanov, Vladimir; Cisneros, Laura; Clausen, Mette R; Cramp, Matthew E; Craxi, Antonio; Croes, Esther A; Dalgard, Olav.
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.. The Lancet Gastroenterology and Hepatology 2017
AHUS Untitled
 
20 Cunningham, Evan B.; Hajarizadeh, Behzad; Dalgard, Olav; Amin, Janaki; Hellard, Margaret; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; Robaeys, Geert; Swan, Tracy; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Bruneau, Julie; Midgard, Håvard; Bourgeois, Stefan; Thurnheer, Maria Christine; Dore, Gregory J.; Grebely, Jason; Shaw, Ineke; Siriragavan, Sharmila; Horschik, Tina; Sharma, Shawn; Eevers, Anita; Andreassen, Jessica; Melkeraaen, Ingunn; Widder, Nicole; Lesneuck, Kristof; Kotsoros, Barbara; Hazelwood, Susan; Holland, Rohan; Axten, David; Von Bibra, Sally; Powis, Jeff; Mason, Kate; Ryder, Stephen; Jack, Kate; Scheidegger, Claude; Huber, Christine; Ferguson, Catherine; Staehelin, Cornelia; Lacalamita, Melanie; Fragomeli, Vincenzo; Sevehon, Alison.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study. BMC Infectious Diseases 2017 ;Volume 17.(1)
AHUS Untitled
 
21 Dalgard, Olav; Weiland, Ola; Noraberg, Geir; Karlsen, Lars Normann; Heggelund, Lars; Färkkilä, Martti; Balslev, Ulla; Belard, Erika; Øvrehus, Anne; Kjær, Mette Skalshøi; Krarup, Henrik; Røge, Birgit Thorup; Hallager, Sofie; Madsen, Lone G.; Laursen, Alex Lund; Lagging, Martin; Weis, Nina.
Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections - A Scandinavian real-life study. PLOS ONE 2017 ;Volume 12:e0179764.(7) p. 1-8
AHUS SSHF SUS UiO VV Untitled
 
22 Grebely, Jason; Bruneau, Julie; lazarus, jeffrey; Dalgard, Olav; Bruggmann, Philip; Treloar, Carla; hickman, matthew; Hellard, Margaret; Roberts, Teri; Crooks, Levinia; Midgard, Håvard; Larney, Sarah; Degenhardt, Louisa; Alho, Hannu; Byrne, Jude; Dillon, John F.; Feld, Jordan J.; Foster, Graham; Goldberg, David E.; Lloyd, Andrew R.; Reimer, Jens; Robaeys, Geert; Torrens, Marta; Wright, Nat; Maremmani, Icro; Norton, Brianna L.; Litwin, Alain H.; Dore, Gregory J..
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.. International journal of drug policy 2017 ;Volume 47. p. 51-60
AHUS OUS UiO Untitled
 
23 Grebely, Jason; Dalgard, Olav; Cunningham, Evan B.; Hajarizadeh, Behzad; Foster, Graham R.; Bruggmann, Philip; Conway, Brian; Backmund, Markus; Robaeys, Geert; Swan, Tracy; Amin, Janaki; Marks, Philippa S.; Quiene, Sophie; Applegate, Tanya L.; Weltman, Martin; Shaw, David; Dunlop, Adrian; Hellard, Margaret; Bruneau, Julie; Midgard, Håvard; Bourgeois, Stefan; Staehelin, Cornelia; Dore, Gregory J..
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study. International journal of drug policy 2017 ;Volume 47. p. 177-186
AHUS OUS UiO Untitled
 
24 Grebely, Jason; Swan, Tracy; hickman, matthew; Bruneau, Julie; Bruggmann, Philip; Dalgard, Olav; Litwin, Alain H.; Backmund, Markus; Dore, Gregory J..
Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C. Journal of Hepatology 2017 ;Volume 66.(5) p. 1101-1103
AHUS Untitled
 
25 Lamoury, François M.J.; Soker, Angelica; Martinez, Danica; Hajarizadeh, Behzad; Cunningham, Evan B.; Cunningham, Philip; Bruggmann, Philip; Foster, Graham R.; Dalgard, Olav; Backmund, Markus; Conway, Brian; Robaeys, Geert; Swan, Tracy; Cloherty, Gavin; Marks, Pip; Grebely, Jason; Dore, Gregory J.; Applegate, Tanya L..
Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse. Journal of Clinical Virology 2017 ;Volume 92. p. 32-38
AHUS UiO Untitled
 
26 Meijerink, Hinta; White, Richard; Løvlie, Astrid Louise; De Blasio, Birgitte Freiesleben; Dalgard, Olav; Amundsen, Ellen Johanna; Melum, Espen; Kløvstad, Hilde.
Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030. BMC Infectious Diseases 2017 ;Volume 17. p. -
AHUS FHI OUS UiO Untitled
 
27 Midgard, Håvard; Hajarizadeh, Behzad; Cunningham, Evan B.; Conway, Brian; Backmund, Markus; Bruggmann, Philip; Bruneau, Julie; Bourgeois, Stefan; Dunlop, Adrian; Foster, Graham R.; Hellard, Margaret; Robaeys, Geert; Thurnheer, Maria C; Weltman, Martin; Amin, Janaki; Marks, Philippa S; Quiene, Sophie; Dore, Gregory J.; Dalgard, Olav; Grebely, Jason.
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study. International journal of drug policy 2017 ;Volume 47. p. 230-238
AHUS OUS UiO Untitled
 
2016
28 Dore, Gregory J.; Altice, Frederick; Litwin, Alain H; Dalgard, Olav; Gane, Edward J.; Shibolet, Oren; Luetkemeyer, Anne; Nahass, Ronald; Peng, Cheng-Yuan; Conway, Brian; Grebely, Jason; Howe, Anita YM; Gendrano, Isaias N; Chen, Erluo; Huang, Hsueh-Cheng; Dutko, Frank J; Nickle, David C.; Nguyen, Bach-Yen; Wahl, Janice; Barr, Eliav; Robertson, Michael N; Platt, Heather L.
Elbasvir-grazoprevir to treat hepatitis C virus infection in persons receiving opioid agonist therapy a randomized trial. Annals of Internal Medicine 2016 ;Volume 165.(9) p. 625-634
AHUS Untitled
 
29 Dore, Gregory J.; Conway, Brian; Luo, Yan; Janczewska, Ewa; Knysz, Brygida; Liu, Yan; Streinu-Cercel, Adrian; Caruntu, Florin Alexandru; Curescu, Manuela; Skoien, Richard; Ghesquiere, Wayne; Mazur, Wlodzimierz; Soza, Alejandro; Fuster, Francisco; Greenbloom, Susan; Motoc, Adriana; Arama, Victoria; Shaw, David; Tornai, Istvan; Sasadeusz, Joseph; Dalgard, Olav; Sullivan, Danielle; Liu, Xuan; Kapoor, Mudra; Campbell, Andrew; Podsadecki, Thomas.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials. Journal of Hepatology 2016 ;Volume 64.(1) p. 19-28
AHUS Untitled
 
30 Midgard, Håvard; Bjøro, Benedikte; Mæland, Arild; Zbigniew, Konopski; Kileng, Hege; Damås, Jan Kristian; Paulsen, Jørn; Heggelund, Lars; Sandvei, Per; Ringstad, Jetmund; Karlsen, Lars Normann; Stene-Johansen, Kathrine; Pettersson, John; Dorenberg, Dagny Haug; Dalgard, Olav.
Hepatitis C reinfection after sustained virological response. Journal of Hepatology 2016 ;Volume 64.(5) p. 1020-1026
AHUS FHI NTNU OSTFSYK OUS STHF STO SUS UiO UNN VV Untitled
 
31 Midgard, Håvard; Bramness, Jørgen Gustav; Skurtveit, Svetlana; Haukeland, John Willy; Dalgard, Olav.
Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study. PLOS ONE 2016 ;Volume 11.(11) p. -
AHUS FHI OUS UiO Untitled
 
32 Midgard, Håvard; Weir, Amanda; Palmateer, Nora; Lo Ve 3rd, Vincent; Pineda, Juan A.; Macias, Juan; Dalgard, Olav.
HCV epidemiology in high-risk groups and the risk of reinfection.. Journal of Hepatology 2016 ;Volume 1 Suppl. p. 33-45
AHUS OUS UiO Untitled
 
33 Razavi-Shearer, D; Dalgard, Olav; Midgard, Håvard; Razavi, H; Wüsthoff, Linda Elise; Kielland, Knut Boe.
Aggressive treatment of hepatitis C in People who inject drugs in Norway: an integral step to eradicate the infection in this population. 5th International Symposium on Hepatitis Care in Substance Users; 2016-09-07 - 2016-09-09
AHUS SI Untitled
 
34 Waldenström, Jesper; Westin, Johan; Nyström, Kristina; Christensen, Peer; Dalgard, Olav; Färkkilä, Martti; Lindahl, Karin; Nilsson, Staffan; Norkrans, Gunnar; Krarup, Henrik; Norrgren, Hans; Buhl, Mads Rauning; Stenmark, Stephan; Lagging, Martin.
Randomized trial evaluating the impact of ribavirin mono-therapy and double dosing on viral kinetics, ribavirin pharmacokinetics and anemia in hepatitis C virus genotype 1 infection. PLOS ONE 2016 ;Volume 11.(5)
AHUS Untitled
 
2015
35 Dalgard, Olav; Martinot-Peignoux, Michelle; Verbaan, Hans; Bjøro, Kristian; Ring-Larsen, Helmer; Marcellin, Patrick.
The usefulness of defining rapid virological response by a very sensitive assay (TMA) during treatment of HCV genotype 2/3 infection. PLOS ONE 2015 ;Volume 10.(8) p. -
AHUS OUS UiO Untitled
 
36 Gane, Edward J.; Kershenobich, D; Seguin-Devaux, C; Kristian, P; Aho, I; Dalgard, Olav; Shestakova, I; Nymadawa, P; Blach, S; Acharya, S; Anand, AC; Andersson, MI; Arendt, V; Arkkila, P; Baatarkhuu, O; Barclay, K; Ben-Ari, Z; Bergin, C; Bessone, F; Blokhina, N; Brunton, CR; Choudhuri, G; Chulanov, V; Cisneros, L; Croes, EA; Dahgwahdorj, YA; Daruich, JR; Dashdorj, NR; Davaadorj, D; De Knegt, RJ; De Vree, M; Gadano, AC; Gower, E; Halota, W; Hatzakis, A; Henderson, C; Hoffmann, P; Hornell, J; Houlihan, D; Hrusovsky, S; Jarcuska, P; Kostrzewska, K; Leshno, M; Lurie, Y; Mahomed, A; Mamonova, N; Mendez-Sanchez, N; Mossong, J; Norris, S; Nurmukhametova, E; Oltman, M; Oyunbileg, J; Oyunsuren, Ts; Papatheodoridis, G; Pimenov, N; Prins, M; Puri, P; Radke, S; Rakhmanova, A; Razavi, H; Razavi-Shearer, K; Reesink, HW; Ridruejo, E; Safadi, R; Sagalova, O; Sanchez Avila, JF; Sanduijav, R; Saraswat, V; Schreter, I; Shah, SR; Shevaldin, A; Shibolet, O; Silva, MO; Sokolov, S; Sonderup, M; Souliotis, K; Spearman, CW; Staub, T; Stedman, C; Strebkova, EA; Struck, D; Sypsa, V; Tomasiewicz, K; Undram, L; Van Der Meer, AJ; Van Santen, D; Veldhuijzen, I; Villamil, FG; Willemse, S; Zuckerman, E; Zuure, FR; Prabdial-Sing, N; Flisiak, R; Estes, Chris R..
Strategies to manage hepatitis C virus (HCV) infection disease burden - Volume 2. Journal of Viral Hepatitis 2015 ;Volume 22.(1) p. 46-73
AHUS Untitled
 
37 Hatzakis, Angelos; Chulanov, V; Gadano, AC; Bergin, C; Ben-Ari, Z; Mossong, J; Schreter, I; Baatarkhuu, O; Acharya, S; Aho, I; Anand, AC; Andersson, MI; Arendt, V; Arkkila, P; Barclay, K; Bessone, F; Blach, S; Blokhina, N; Brunton, CR; Choudhuri, G; Cisneros, L; Croes, EA; Dahgwahdorj, YA; Dalgard, Olav; Daruich, JR; Dashdorj, NR; Davaadorj, D; De Knegt, RJ; De Vree, M; Estes, C; Flisiak, R; Gane, E; Gower, E; Halota, W; Henderson, C; Hoffmann, P; Hornell, J; Houlihan, D; Hrusovsky, S; Jarcuska, P; Kershenobich, D; Kostrzewska, K; Kristian, P; Leshno, M; Lurie, Y; Mahomed, A; Mamonova, N; Mendez-Sanchez, N; Norris, S; Nurmukhametova, E; Nymadawa, P; Oltman, M; Oyunbileg, J; Oyunsuren, T; Papatheodoridis, G; Pimenov, N; Prabdial-Sing, N; Prins, M; Radke, S; Rakhmanova, A; Razavi-Shearer, K; Reesink, HW; Ridruejo, E; Safadi, R; Sagalova, O; Sanchez Avila, JF; Sanduijav, R; Saraswat, V; Seguin-Devaux, C; Shah, SR; Shestakova, I; Shevaldin, A; Shibolet, O; Silva, MO; Sokolov, S; Sonderup, M; Souliotis, K; Spearman, CW; Staub, T; Stedman, C; Strebkova, EA; Struck, D; Sypsa, V; Tomasiewicz, K; Undram, L; Van Der Meer, AJ; Van Santen, D; Veldhuijzen, I; Villamil, FG; Willemse, S; Zuckerman, E; Zuure, FR; Puri, P; Razavi, Homie A..
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - Volume 2. Journal of Viral Hepatitis 2015 ;Volume 22.(1) p. 26-45
AHUS Untitled
 
38 Hjerrild, Simon; Dalgard, Olav; Christensen, Peer Brehm; Leutscher, Peter.
Debilitating fatigue as a treatment indication in chronic hepatitis C. Journal of Hepatology 2015 ;Volume 63.(6) p. 1533-1533
AHUS UiO Untitled
 
39 Isaksen, Kjetil; Aabakken, Lars; Grimstad, Tore; Karlsen, Lars Normann; Sandvei, Per; Dalgard, Olav.
Hepatitt C-behandling ved tre norske sykehus 2000–11. Tidsskrift for Den norske legeforening 2015 ;Volume 135.(22) p. 2052-2058
AHUS OSTFSYK OUS SUS Untitled
 
40 Saraswat, Vivek Anand; Norris, S; De Knegt, RJ; Sanchez Avila, JF; Sonderup, M; Zuckerman, E; Arkkila, P; Stedman, C; Acharya, S; Aho, I; Anand, AC; Andersson, MI; Arendt, V; Baatarkhuu, O; Barclay, K; Ben-Ari, Z; Bergin, C; Bessone, F; Blach, S; Blokhina, N; Brunton, CR; Choudhuri, G; Chulanov, V; Cisneros, L; Croes, EA; Dahgwahdorj, YA; Dalgard, Olav; Daruich, JR; Dashdorj, NR; Davaadorj, D; De Vree, M; Estes, C; Flisiak, R; Gadano, AC; Gane, E; Halota, W; Hatzakis, A; Henderson, C; Hoffmann, P; Hornell, J; Houlihan, D; Hrusovsky, S; Jarcuska, P; Kershenobich, D; Kostrzewska, K; Kristian, P; Leshno, M; Lurie, Y; Mahomed, A; Mamonova, N; Mendez-Sanchez, N; Mossong, J; Nurmukhametova, E; Nymadawa, P; Oltman, M; Oyunbileg, J; Oyunsuren, T; Papatheodoridis, G; Pimenov, N; Prabdial-Sing, N; Prins, M; Puri, P; Radke, S; Rakhmanova, A; Razavi, H; Razavi-Shearer, K; Reesink, HW; Ridruejo, E; Safadi, R; Sagalova, O; Sanduijav, R; Schreter, I; Seguin-Devaux, C; Shah, SR; Shestakova, I; Shevaldin, A; Shibolet, O; Sokolov, S; Souliotis, K; Spearman, CW; Staub, T; Strebkova, EA; Struck, D; Tomasiewicz, K; Undram, L; Van Der Meer, AJ; Van Santen, D; Veldhuijzen, I; Villamil, FG; Willemse, S; Zuure, FR; Silva, MO; Sypsa, V; Gower, Erin E..
Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2. Journal of Viral Hepatitis 2015 ;Volume 22.(1) p. 6-25
AHUS Untitled
 
2014
41 Kielland, Knut Boe; Amundsen, Ellen Johanna; Dalgard, Olav.
HCV treatment uptake in people who have injected drugs — observations in a large cohort that received addiction treatment 1970–1984. Scandinavian Journal of Gastroenterology 2014 ;Volume 49.(12) p. 1465-1472
AHUS FHI SI UiO Untitled
 
42 Kielland, Knut Boe; Delaveris, Gerd Jorunn Møller; Rogde, Sidsel; Eide, Tor Jacob; Amundsen, Ellen Johanna; Dalgard, Olav.
Liver fibrosis progression at autopsy in injecting drug users infected by hepatitis C: A longitudinal long-term cohort study. Journal of Hepatology 2014 ;Volume 60.(2) p. 260-266
AHUS FHI OUS SI UiO Untitled
 
2013
43 Grady, Bart P.; Schinkel, Janke; Thomas, Xiomara V.; Dalgard, Olav.
Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs. Clinical Infectious Diseases 2013 ;Volume 57. p. S105-S110
AHUS Untitled
 
44 Kielland, Knut Boe; Amundsen, Ellen Johanna; Dalgard, Olav.
Treatment uptake of HCV-infection in a Norwegian cohort of people who inject drugs.. 3rd International symposium on hepatitis care in substance users; 2013-09-05 - 2013-09-06
FHI SI UiO Untitled
 
45 Kielland, Knut Boe; Delaveris, Gerd Jorunn Møller; Rogde, Sidsel; Amundsen, Ellen Johanna; Eide, Tor Jacob; Dalgard, Olav.
Liver fibrosis among people who inject drugs exposed to hepatitis C, assessed through examination of liver tissue from autopsies. 3rd International Symposium on Hepatitis Care in Substance Users; 2013-09-05 - 2013-09-06
FHI SI UiO Untitled
 
46 Kielland, Knut Boe; Skaug, Kjell; Amundsen, Ellen Johanna; Dalgard, Olav.
All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study. Journal of Hepatology 2013 ;Volume 58.(1) p. 31-37
AHUS FHI SI Untitled
 
47 Lagging, Martin; Rembeck, Karolina; Buhl, Mads Rauning; Christensen, Peer Brehm; Dalgard, Olav; Färkkilä, Martti; Hellstrand, Kristoffer; Langeland, Nina; Lindh, Mats; Westin, Johan; Norkrans, Gunnar.
Retreatment with peg-interferon and ribavirin in patients with chronic hepatitis C virus genotype 2 or 3 infection with prior relapse. Scandinavian Journal of Gastroenterology 2013 ;Volume 48.(7) p. 839-847
AHUS UiB Untitled
 
48 Robaeys, Geert; Grebely, Jason; Mauss, Stefan; Bruggmann, Philip; Moussalli, Joseph; De Gottardi, Andrea; Swan, Tracy; Arain, Amber; Kautz, Achim; Stöver, Heino; Wedemeyer, Heiner; Schaefer, M; Taylor, L; Backmund, Markus; Dalgard, Olav; Prins, Maria; Dore, Gregory J..
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clinical Infectious Diseases 2013 ;Volume 57. p. S129-S137
AHUS Untitled
 
2012
49 Béziat, Vivien; Dalgard, Olav; Asselah, Tarik; Halfon, Philippe; Bedossa, Pierre; Boudifa, Ali; Hervier, Baptiste; Theodorou, Ioannis; Martinot, Michelle; Debre, Patrice; Björkström, Niklas K; Malmberg, Karl-Johan; Marcellin, Patrick; Vieillard, Vincent.
CMV drives clonal expansion of NKG2C(+) NK cells expressing self-specific KIRs in chronic hepatitis patients. European Journal of Immunology 2012 ;Volume 42.(2) p. 447-457
OUS Untitled
 
50 Eskesen, Arne N; Melum, Espen; Moghaddam, Amir; Bjøro, Kristian; Verbaan, Hans; Ring-Larsen, Helmer; Dalgard, Olav.
Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European Journal of Gastroenterology and Hepathology 2012 ;Volume 24.(8) p. 890-896
AHUS OUS Untitled
 
    Show next list